IQVIA™ Real-World Insights Bibliography

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
Author(s): Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims; Christopher LeMay; Jimmie Mancell; Lisa L Maragakis
Affiliations(s): 1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue) 2 Hospital for Special Surgery (DiFiori) 3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay) 4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad) 5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson) 6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho) 7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell) 8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis)
Publication(s):  JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
Author(s): Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett , Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri
Affiliations(s): D'Andrea: Harvard; Largent: IQVIA
Publication(s):  http://orcid.org/0000-0002-5263-3964PubMed articles
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Methodology,
2021
  L:
A:
English
Literature Review,
  Add to report
 
 
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
Author(s): Grammati Sarri 1, Elisabetta Patorno 2, Hongbo Yuan 3, Jianfei Jeff Guo 4, Dimitri Bennett 5, Xuerong Wen 6, Andrew R Zullo 7, Joan Largent 8, Mary Panaccio 9, Mugdha Gokhale 10, Daniela Claudia Moga 11, M Sanni Ali 12 13 14, Thomas P A Debray 15 16
Affiliations(s): 1Real World Evidence Sciences, Visible Analytics Ltd, Oxford, UK grammati.sarri@visibleanalytics.co.uk. 2Division of Pharmacoepidemiology and Pharmacoeconomics, Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada. 4Department of Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA. 5Takeda, Cambridge, Massachusetts, USA. 6Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. 7Health Services, Policy, and Practice, Brown University, Providence, Rhode Island, USA. 8Real-World Solutions, IQVIA, California, Colorado, USA. 9Epidemiology and Outcomes Research, Research Outcomes Innovations LLC, New York City, New York, USA. 10GlaxoSmithKline USA, Philadelphia, Pennsylvania, USA. 11University of Kentucky, Department of Pharmacy Practice and Science, Lexington, Kentucky, USA. 12NDORMS, Center for Statistics in Medicine, University of Oxford, Oxford, UK. 13Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 14Department of Public Heath, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 15Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. 16Smart Data Analysis and Statistics, Utrecht, The Netherlands.
Publication(s):  PMID: 33298465 DOI: 10.1136/bmjebm-2020-111493
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Methodology,
2021
  L:
A:
English
Literature Review,
  Add to report
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults ? A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publication(s): 
Document Type(s): Article,
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study,
  Add to report
 
 
Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia
Author(s): Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C
Affiliations(s): Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS
Publication(s):  Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993.
Document Type(s): Article,
Countries: Italy, USA,
Click here for the abstract
C:
Y:
Mental health, Metabolic Disorders ,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014
Author(s): Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor LG, Hua W, Horn P, Trinidad JP, Boudreau DM
Affiliations(s): "L Taylor: EPI OR, RWS, IQVIA; 1Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 2Meyers Primary Care Institute, Worcester, Massachusetts, USA. 3Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, Chapman University, School of Pharmacy, Irvine, CA, USA. 4Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 5Institute for Health Research, Kaiser Permanente Colorado, Colorado, USA. 6Kaiser Permanente Center for Health Research, Portland, Oregon, USA. 7Kaiser Foundation Research Institute, Oakland, California, USA. 8Health Partners Institute, Bloomington, Minnesota, USA. 9Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 10Food and Drug Administration, Silver Spring, Maryland, USA."
Publication(s):  Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1541-1550. doi: 10.1002/pds.5312.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Drug Utlization Study, Womens Health,
2021
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System
Author(s): Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D
Affiliations(s): "1The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. 3Department of Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, Massachusetts, USA. 4Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. / L Taylor - IQVIA - RWS 5Department of Scientific Affairs, HealthCore, Inc., Wilmington, Delaware, USA. 6Community Health Care Family Medicine Residency, Tacoma, Washington, USA. 7CVS Health Clinical Trial Services, Part of the CVS Health Family of Companies, Blue Bell, Pennsylvania, USA. 8Kaiser Permanente Center for Integrated Health Care Research Hawaii and Office of Public Health Studies, University of Hawai'i Manoa, Honolulu, Hawaii, USA."
Publication(s):  "Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11. PMID: 34089206"
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Womens Health,
2021
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety.
Author(s): Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-GabarrĂ³ 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13
Affiliations(s): 1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.
Document Type(s): Article,
Countries: Belgium, Germany, UK, USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods,
2021
  L:
A:
English
Patient questionnaire, Review,
  Add to report
 
 
Modernizing Oncology Approvals
Author(s): Christina Mack
Affiliations(s): CAEG
Publication(s):  PharmaVoice. 2021 Mar
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Oncology,
2021
  L:
A:
English
clinical setting: Secondary care,
  Add to report
 
 
Real-world evidence to support regulatory decision making: New or expanded medical product indications
Author(s): Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA.
Affiliations(s): 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 2Center for Observational and Real-world Evidence, Merck & Co., Inc, Kenilworth, New Jersey, USA. 3Research & Development Strategy and Operations, Amgen, Thousand Oaks, California, USA. 4Real World Solutions, IQVIA, Cambridge, Massachusetts, USA.
Publication(s):  Pharmacoepidemiol Drug Saf . 2021 Jun;30(6):685-693. doi: 10.1002/pds.5222. Epub 2021 Mar 18.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Guidelines, Regulatory,
2021
  L:
A:
English
Real World Data, Real World Evidence,
  Add to report
 
 
First Page Previous Page  2 of 71 Next Page Last Page